Company News in the Life Science Industry

»

Reset 

HTL-STREFA, Inc's. Prevent® DropSafe(TM) Safety Pen Needles are the 2019 New Product of the Year

MARIETTA, Ga., Jan. 17, 2020 /PRNewswire/ -- HTL-STREFA, a leading medical device company belonging to MTD Group (www.mtdglobal.com),... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

North & South America and China Companion Animal Diagnostics Market Report, 2019-2027 - Parasitology Expected to be a $447.03 Million Opportunity by 2027

DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

Seneca Biopharma Announces Exercise of Warrants for $7.55 Million Gross Proceeds Priced At-the-Market

GERMANTOWN, Md., Jan. 17, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced the agreement by several accredited investors to exercise certain warrants... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Seneca Biopharma, Inc.

Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium

NUTLEY, N.J., Jan. 17, 2020 /PRNewswire/ -- Genomic medicine's groundbreaking treatments, and its future promise, will be the focus of a full-day symposium at the Hackensack Meridian Health Center for Discovery and Innovation (CDI) on Wednesday, February 19.

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2020

Canopy Growth Revises Beverage Launch Timeline

SMITHS FALLS, ON, Jan. 17, 2020 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED), (NYSE: CGC) submitted its final documentation for its beverage facility to Health Canada in late June 2019 and subsequently received the licence in late November 2019. In the... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer

Read more ››
By: GlobenewsWire - 17 Jan 2020
Related companies:  Veloxis Pharmaceuticals A/S

Algernon Pharmaceuticals Appoints Novotech as CRO for First Phase 2 Trial and Announces Novotech’s $220K Equity Investment

Read more ››
By: GlobenewsWire - 17 Jan 2020
Related companies:  Algernon Pharmaceuticals Inc.

I-MAB Announces Pricing of U.S. Initial Public Offering

Read more ››
By: GlobenewsWire - 17 Jan 2020
Related companies:  I-Mab Biopharma

Novelion Therapeutics Confirms Commencement of Voluntary Liquidation

Read more ››
By: GlobenewsWire - 17 Jan 2020
Related companies:  Novelion Therapeutics Inc.

US Patent Office Issues DisposeRx First Patent

SANFORD, N.C., Jan. 16, 2020 /PRNewswire/ -- DisposeRx, Inc. has received its first patent from the US Patent and Trademark Office.... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  DisposeRx Inc.

The Valens Company Secures DTC Eligibility

KELOWNA, BC, Jan. 16, 2020 /CNW/ - Valens GroWorks Corp (TSXV: VLNS) (OTCQX: VLNCF) (the "Company", "Valens" or "The Valens Company"), a vertically integrated provider of industry-leading extraction products and services; including a diverse suite of extraction... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Valens GroWorks Corp.

Cerner Named Best in Client Service and Technical Support for Fourth Consecutive Year

Read more ››
By: GlobenewsWire - 16 Jan 2020
Related companies:  Cerner Corporation

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobenewsWire - 16 Jan 2020
Related companies:  Apellis Pharmaceuticals, Inc.

Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes and established CVD

Read more ››
By: GlobenewsWire - 16 Jan 2020

The American Foundation for Suicide Prevention Thanks Congressional Suicide Prevention Champions for Introducing the Suicide Prevention Act

WASHINGTON, Jan. 16, 2020 /PRNewswire/ -- On January 15, Representatives Matsui (D-CA-6), Stewart (R-UT-2) and with Senators Kennedy (R-LA) and Reed (D-RI) introduced the Suicide Prevention Act (H.R.5619/S.3198). John Madigan, senior vice president of public policy for the Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

Berkeley Lights' CEO Eric Hobbs Speaks to The Future of Cell-based Products and Therapeutics in Presentation at Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 16, 2020 /PRNewswire/ -- Eric Hobbs, Ph.D., CEO of Berkeley Lights, spoke at the annual J.P. Morgan Healthcare Conference on Tuesday to a fully-packed room of industry leaders and the investment community about Berkeley Lights' technology, vision for the future, and upcoming... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  Berkeley Lights Inc.

Statement from Jeff Shuren, M.D., J.D., director of FDA's Center for Devices and Radiological Health on quality issues with certain Cardinal Health surgical gowns and packs

SILVER SPRING, Md., Jan. 16, 2020 /PRNewswire/ -- On Jan. 11 and again on Jan. 15, 2020, medical device manufacturer Cardinal Health alerted its customers to potential quality issues affecting some of its Level 3 surgical gowns and PreSource procedural packs that contain these gowns. Cardinal... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  U.S. Food and Drug Administration

MCRA Strengthens its Reimbursement, Health Economics, and Market Access Division with the Hiring of Tess Wong, MS

WASHINGTON, Jan. 16, 2020 /PRNewswire/ -- MCRA, LLC, is a leading clinical research organization (CRO) and advisory firm specializing in medical devices and biologics. Its integration of regulatory, clinical research, reimbursement, compliance, and quality assurance assists companies in bringing... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

BiondVax Announces Warrant Agreement Amendment to Permit Holders of Warrants to Exercise Both on a Cash and Cashless Basis

JERUSALEM, Jan. 16, 2020 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, announced that effective January 16, 2020, the Company will permit holders... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

Lilly Confirms Date and Conference Call for Fourth-Quarter 2019 Financial Results Announcement

INDIANAPOLIS, Jan. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2019 financial results on Thursday, January 30, 2020. Lilly will also conduct a conference call on that day with the investment community and media to further detail the... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  Eli Lilly and Company
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies